Cargando…
Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization
BACKGROUND: We aimed to elucidate household and community-level shedding and transmission of trivalent oral polio vaccine (tOPV) in communities with inactivated polio vaccine (IPV) routine immunization after tOPV is administered during a national health week (NHW). METHODS: We conducted a 3-arm, ran...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206104/ https://www.ncbi.nlm.nih.gov/pubmed/30376084 http://dx.doi.org/10.1093/cid/ciy606 |
_version_ | 1783366302227759104 |
---|---|
author | Sarnquist, Clea Holubar, Marisa García-García, Lourdes Ferreyra-Reyes, Leticia Delgado-Sánchez, Guadalupe Cruz-Hervert, Luis Pablo Montero-Campos, Rogelio Altamirano, Jonathan Purington, Natasha Boyle, Shanda Modlin, John Ferreira-Guerrero, Elizabeth Canizales-Quintero, Sergio Díaz Ortega, José Luis Desai, Manisha Maldonado, Yvonne A |
author_facet | Sarnquist, Clea Holubar, Marisa García-García, Lourdes Ferreyra-Reyes, Leticia Delgado-Sánchez, Guadalupe Cruz-Hervert, Luis Pablo Montero-Campos, Rogelio Altamirano, Jonathan Purington, Natasha Boyle, Shanda Modlin, John Ferreira-Guerrero, Elizabeth Canizales-Quintero, Sergio Díaz Ortega, José Luis Desai, Manisha Maldonado, Yvonne A |
author_sort | Sarnquist, Clea |
collection | PubMed |
description | BACKGROUND: We aimed to elucidate household and community-level shedding and transmission of trivalent oral polio vaccine (tOPV) in communities with inactivated polio vaccine (IPV) routine immunization after tOPV is administered during a national health week (NHW). METHODS: We conducted a 3-arm, randomized trial with data collected at baseline through 10 weeks post-NHW in households with at least 1 child <5 years old in 3 semi-rural communities in Orizaba, Mexico. Selected communities were geographically isolated but socio-demographically similar. Each community was assigned an oral polio vaccine (OPV) immunization rate: 10, 30, or 70% of participating households. From 2653 households in the 3 communities, ~150 households per community were selected, for 466 in total. Households were randomized as vaccinated or unvaccinated, with only 1 child under 5 in the vaccinated household receiving OPV during the February 2015 NHW. No other community members received OPV during this NHW. Stool samples were collected up to 10 weeks post-vaccination for all members of the 466 study households and were analyzed for the presence of OPV serotypes using a multiplex polymerase chain reaction assay. RESULTS: We will report on the factors associated with, and incidence and duration of, household and community shedding and transmission of OPV. The secondary outcomes will characterize temporal and geospatial OPV serotype shedding patterns. CONCLUSIONS: The current global polio eradication plan relies on transitioning away from OPV to IPV. This study contributes to understanding patterns of OPV shedding and transmission dynamics in communities with primary IPV immunity, in order to optimize the reduction of OPV transmission. |
format | Online Article Text |
id | pubmed-6206104 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62061042018-11-02 Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization Sarnquist, Clea Holubar, Marisa García-García, Lourdes Ferreyra-Reyes, Leticia Delgado-Sánchez, Guadalupe Cruz-Hervert, Luis Pablo Montero-Campos, Rogelio Altamirano, Jonathan Purington, Natasha Boyle, Shanda Modlin, John Ferreira-Guerrero, Elizabeth Canizales-Quintero, Sergio Díaz Ortega, José Luis Desai, Manisha Maldonado, Yvonne A Clin Infect Dis Supplement Articles BACKGROUND: We aimed to elucidate household and community-level shedding and transmission of trivalent oral polio vaccine (tOPV) in communities with inactivated polio vaccine (IPV) routine immunization after tOPV is administered during a national health week (NHW). METHODS: We conducted a 3-arm, randomized trial with data collected at baseline through 10 weeks post-NHW in households with at least 1 child <5 years old in 3 semi-rural communities in Orizaba, Mexico. Selected communities were geographically isolated but socio-demographically similar. Each community was assigned an oral polio vaccine (OPV) immunization rate: 10, 30, or 70% of participating households. From 2653 households in the 3 communities, ~150 households per community were selected, for 466 in total. Households were randomized as vaccinated or unvaccinated, with only 1 child under 5 in the vaccinated household receiving OPV during the February 2015 NHW. No other community members received OPV during this NHW. Stool samples were collected up to 10 weeks post-vaccination for all members of the 466 study households and were analyzed for the presence of OPV serotypes using a multiplex polymerase chain reaction assay. RESULTS: We will report on the factors associated with, and incidence and duration of, household and community shedding and transmission of OPV. The secondary outcomes will characterize temporal and geospatial OPV serotype shedding patterns. CONCLUSIONS: The current global polio eradication plan relies on transitioning away from OPV to IPV. This study contributes to understanding patterns of OPV shedding and transmission dynamics in communities with primary IPV immunity, in order to optimize the reduction of OPV transmission. Oxford University Press 2018-11-15 2018-10-30 /pmc/articles/PMC6206104/ /pubmed/30376084 http://dx.doi.org/10.1093/cid/ciy606 Text en © The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Supplement Articles Sarnquist, Clea Holubar, Marisa García-García, Lourdes Ferreyra-Reyes, Leticia Delgado-Sánchez, Guadalupe Cruz-Hervert, Luis Pablo Montero-Campos, Rogelio Altamirano, Jonathan Purington, Natasha Boyle, Shanda Modlin, John Ferreira-Guerrero, Elizabeth Canizales-Quintero, Sergio Díaz Ortega, José Luis Desai, Manisha Maldonado, Yvonne A Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization |
title | Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization |
title_full | Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization |
title_fullStr | Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization |
title_full_unstemmed | Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization |
title_short | Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization |
title_sort | protocol paper: oral poliovirus vaccine transmissibility in communities after cessation of routine oral poliovirus vaccine immunization |
topic | Supplement Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206104/ https://www.ncbi.nlm.nih.gov/pubmed/30376084 http://dx.doi.org/10.1093/cid/ciy606 |
work_keys_str_mv | AT sarnquistclea protocolpaperoralpoliovirusvaccinetransmissibilityincommunitiesaftercessationofroutineoralpoliovirusvaccineimmunization AT holubarmarisa protocolpaperoralpoliovirusvaccinetransmissibilityincommunitiesaftercessationofroutineoralpoliovirusvaccineimmunization AT garciagarcialourdes protocolpaperoralpoliovirusvaccinetransmissibilityincommunitiesaftercessationofroutineoralpoliovirusvaccineimmunization AT ferreyrareyesleticia protocolpaperoralpoliovirusvaccinetransmissibilityincommunitiesaftercessationofroutineoralpoliovirusvaccineimmunization AT delgadosanchezguadalupe protocolpaperoralpoliovirusvaccinetransmissibilityincommunitiesaftercessationofroutineoralpoliovirusvaccineimmunization AT cruzhervertluispablo protocolpaperoralpoliovirusvaccinetransmissibilityincommunitiesaftercessationofroutineoralpoliovirusvaccineimmunization AT monterocamposrogelio protocolpaperoralpoliovirusvaccinetransmissibilityincommunitiesaftercessationofroutineoralpoliovirusvaccineimmunization AT altamiranojonathan protocolpaperoralpoliovirusvaccinetransmissibilityincommunitiesaftercessationofroutineoralpoliovirusvaccineimmunization AT puringtonnatasha protocolpaperoralpoliovirusvaccinetransmissibilityincommunitiesaftercessationofroutineoralpoliovirusvaccineimmunization AT boyleshanda protocolpaperoralpoliovirusvaccinetransmissibilityincommunitiesaftercessationofroutineoralpoliovirusvaccineimmunization AT modlinjohn protocolpaperoralpoliovirusvaccinetransmissibilityincommunitiesaftercessationofroutineoralpoliovirusvaccineimmunization AT ferreiraguerreroelizabeth protocolpaperoralpoliovirusvaccinetransmissibilityincommunitiesaftercessationofroutineoralpoliovirusvaccineimmunization AT canizalesquinterosergio protocolpaperoralpoliovirusvaccinetransmissibilityincommunitiesaftercessationofroutineoralpoliovirusvaccineimmunization AT diazortegajoseluis protocolpaperoralpoliovirusvaccinetransmissibilityincommunitiesaftercessationofroutineoralpoliovirusvaccineimmunization AT desaimanisha protocolpaperoralpoliovirusvaccinetransmissibilityincommunitiesaftercessationofroutineoralpoliovirusvaccineimmunization AT maldonadoyvonnea protocolpaperoralpoliovirusvaccinetransmissibilityincommunitiesaftercessationofroutineoralpoliovirusvaccineimmunization |